What’s New

Latest News

News
High-Volume Facilities Are Linked to Improved Survival Outcomes for Patients With MM
06/09/2026
Rebecca Amrick
High-volume facilities are associated with improved outcomes for patients with multiple myeloma (MM), indicating the role physician experience and facility recognition might play in treatment.
High-volume facilities are associated with improved outcomes for patients with multiple myeloma (MM), indicating the role physician experience and facility recognition might play in treatment.
High-volume facilities are...
06/09/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
Ivonescimab Plus Liposomal Irinotecan Demonstrates Second-Line Promise in Small Cell Lung Cancer
06/09/2026
Emily Estrada
Results from a phase 2 study demonstrate that ivonescimab plus liposomal irinotecan shows encouraging efficacy and safety in pretreated patients with small cell lung cancer.
Results from a phase 2 study demonstrate that ivonescimab plus liposomal irinotecan shows encouraging efficacy and safety in pretreated patients with small cell lung cancer.
Results from a phase 2 study...
06/09/2026
Oncology
Oncology
News
Disparities in OB/GYN-Ordered CRC Screenings Based on Age, Race, and Income
06/09/2026
Rebecca Amrick
Obstetrician/gynecologist (OB/GYN) offices may serve as an additional setting to inform women on colorectal cancer (CRC) and provide preventative screenings, but discrepancies in care still exist based on age, race, income, and insurance...
Obstetrician/gynecologist (OB/GYN) offices may serve as an additional setting to inform women on colorectal cancer (CRC) and provide preventative screenings, but discrepancies in care still exist based on age, race, income, and insurance...
Obstetrician/gynecologist...
06/09/2026
First Report Managed Care
First Report Managed Care
News
Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds
06/09/2026
Jessica Garlewicz
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly prevalent among adults with severe atopic dermatitis (AD) and appear closely associated with disease severity.
Nail abnormalities may be highly...
06/09/2026
The Dermatologist
The Dermatologist
Research Highlights
IBS-C Microbiome Signatures Offer Insights Into Parkinson’s-Related Constipation
06/09/2026
Rebecca Mashaw
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation
New research highlights...
06/09/2026
Gastroenterology
Gastroenterology
a doctor reviews brain scans
News
Reperfusion-Guided Blood Pressure Strategy May Improve Stroke Outcomes
06/09/2026
Maria Mantas
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
A multicenter randomized...
06/09/2026
Neurology
Neurology
AeroClave sanitizing unit
News
Ebola Preparedness: What EMS Agencies Need to Know About Decontamination and Transport Safety
06/08/2026
While the current Ebola outbreak is occurring thousands of miles away, EMS leaders understand that preparation—not reaction—is the key to protecting providers, patients, and communities.
While the current Ebola outbreak is occurring thousands of miles away, EMS leaders understand that preparation—not reaction—is the key to protecting providers, patients, and communities.
While the current Ebola outbreak...
06/08/2026
EMSWorld
EMSWorld

Latest Research

June 2026 issue
The Dermatologist
To Screen or Not to Screen? Rethinking Biologic Monitoring in the Modern Era
Vol. 34, Issue 4, Issue June 2026
CLD May/June 2026
Cath Lab Digest
Thrombus Burden in ALI and the Role of the Rotarex™ Catheter System
Vol. 34, Issue 3, Issue June 2026

HMP Global Learning Network

Featured Interviews

DLBCL, Diffuse Large B-Cell Lymphoma
Videos
Real-World Survival Impact of CAR T Therapy in Advanced DLBCL: Findings From a SEER Database Analysis: Part 2
05/27/2026
Nishanth Thalambedu, MD
This discussion explores the ongoing barriers to CAR T access and the strategies needed to expand equitable treatment for patients with diffuse large B-cell lymphoma (DLBCL).
This discussion explores the ongoing barriers to CAR T access and the strategies needed to expand equitable treatment for patients with diffuse large B-cell lymphoma (DLBCL).
This discussion explores the...
05/27/2026
Journal of Clinical Pathways
Bruce Sands
Research Review
Bruce Sands, MD, on Results from DUET-CD
05/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
05/19/2026
Advances in Inflammatory Bowel Disease Network
pediatric asthma
Videos
Pediatric Video Tutorial: Pediatric Asthma
05/19/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good, but asking two simple questions and listening to them talk can be even better.
Listening for wheezing is good,...
05/19/2026
EMSWorld
CTP News Desk Image
Viewpoints
Skin Substitute Reimbursement Changes 2026: MAC Denials, Q Codes, and What’s Next
05/19/2026
Daniel L. Kapp, MD
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his observations on conflicting Medicare contractor guidance and coding confusion in early 2026 have effectively halting reimbursement for skin substitute applications in one MAC. 
Daniel Kapp, MD, shares his...
05/19/2026
Wounds
CTP News Desk Image
Viewpoint
Operational Observations in a New CTP Regulatory Environment
05/08/2026
Nikki Johnston; Kati Kaushal, DNP, FNP-C, CWS
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these consultants' observations in this new regulatory environment.
Learn more about these...
05/08/2026
Wounds
Advances in Charcot Neuroarthropathy Surgical Techniques Video
Videos
Advances in Charcot Neuroarthropathy Surgical Techniques Video
05/01/2026
Zeeshan S. Husain, DPM, FACFAS, FASPS; Athanasios Garbis, DPM; Kyle Lawton, DPM
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight emerging reconstruction strategies that move beyond traditional rigid fixation toward a more functional approach to limb preservation.
In this video, we highlight...
05/01/2026
Podiatry Today
Jonathan Friedberg, MD
Videos
Nivolumab Plus Doxorubicin, Vinblastine, and Dacarbazine in Advanced Hodgkin Lymphoma
04/30/2026
Jonathan W. Friedberg, MD, MMSc
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc, discusses results from the SWOG S1826 trial which led to the recent FDA approval of nivolumab plus doxorubicin, vinblastine, and dacarbazine for patients with advanced-stage Hodgkin lymphoma.
Jonathan Friedberg, MD, MMSc,...
04/30/2026
Oncology
Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
First Report Managed Care
Rachid Baz, MD
Videos
BCMA-Targeted Bispecifics and CAR-T in Frontline Multiple Myeloma
03/31/2026
Rachid Baz, MD
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the emerging role of BCMA-targeted bispecific antibodies and CAR T-cell therapy in transplant-ineligible patients with newly diagnosed multiple myeloma.
Rachid Baz, MD, discusses the...
03/31/2026
Oncology
Al B. Benson, III, MD, FACP, FASCO
Videos
First-Line Immunotherapy in Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC): Evidence Review
03/31/2026
Al B. Benson, III, MD, FACP, FASCO
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the epidemiology and unmet clinical need in advanced squamous cell carcinoma of the anal canal (SCAC) and examines the evolving role of immunotherapy in the first-line setting. He also contextualizes recent regulatory and...
Dr Benson reviews the...
03/31/2026
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use